Paul B. Manning - Jul 5, 2022 Form 4 Insider Report for Verrica Pharmaceuticals Inc. (VRCA)

Role
Director, 10%+ Owner
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
VRCA
Transactions as of
Jul 5, 2022
Transactions value $
$9,999,998
Form type
4
Date filed
7/5/2022, 04:10 PM
Previous filing
Jun 22, 2022
Next filing
Oct 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRCA Common Stock Purchase $10M +4.76M +53.57% $2.10 13.7M Jul 5, 2022 Direct F1
holding VRCA Common Stock 1.48M Jul 5, 2022 See footnote F2
holding VRCA Common Stock 257K Jul 5, 2022 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by Mr. Manning jointly with his spouse.
F2 The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of BKB and has shared voting and investment power with respect to the shares held by BKB.
F3 The shares are held directly by PBM Capital Investments, LLC ("PBMCI"). The Reporting Person is President and CEO of PBMCI and has sole voting and investment power with respect to the shares held by PBMCI.